Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Human Genetics and Genomic Medicine, |
RCV003128366 | SCV003804239 | likely pathogenic | Neurofibromatosis-Noonan syndrome | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV005099277 | SCV005781818 | pathogenic | Neurofibromatosis, type 1 | 2024-07-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1608Thrfs*12) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of NF1-related conditions (PMID: 31776437). ClinVar contains an entry for this variant (Variation ID: 2430240). For these reasons, this variant has been classified as Pathogenic. |